GeneNews (TSE:GEN) Stock Price Up 7.1%

Shares of GeneNews Ltd (TSE:GENGet Free Report) shot up 7.1% during mid-day trading on Monday . The company traded as high as C$0.15 and last traded at C$0.15. 473,147 shares were traded during mid-day trading, a decline of 68% from the average session volume of 1,480,179 shares. The stock had previously closed at C$0.14.

GeneNews Stock Performance

The stock’s 50 day moving average is C$0.15. The company has a market capitalization of C$25.49 million and a PE ratio of -2.21.

GeneNews Company Profile

(Get Free Report)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Featured Articles

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.